Elpida (elsulfavirine) / Viriom  >>  Phase 1
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Elpida (elsulfavirine) / Viriom
NCT02489435: Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers

Completed
1
36
RoW
VM-1500, Placebo
Viriom
HIV-infection
06/13
06/13
NCT02489487: Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500

Completed
1
24
RoW
VM-1500, Darunavir, Ritonavir, Raltegravir
Viriom
HIV-infection
10/14
10/14
NCT05204121: Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers

Completed
1
36
RoW
Elpida, elsulfavirine, VM-1500, VM1500
Viriom
HIV Infections
04/19
04/19
NCT03706898: Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs

Completed
1
36
RoW
Elpida®, Elsulfavirine, VM1500, VM-1500, Dolutegravir, TIVICAY®, Sofosbuvir, Sovaldi, Daclatasvir, Daklinza®
Viriom
HIV-1-infection, Hepatic Impairment
04/19
04/19
NCT03709355: Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs

Completed
1
56
RoW
Elpida®, elsulfavirine, VM1500, VM-1500, Rifampin, Rifabutin, Clarithromycin, Omeprazole, Atorvastatin, Levonorgestrel+Ethinylestradiol
Viriom
HIV-1-infection
09/19
09/19
NCT03730311: Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers

Unknown status
1
24
RoW
Elpida, elsulfavirine, VM-1500, VM1500, placebo
Viriom
HIV Infections
11/19
12/19
NCT03706911: Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects

Completed
1
27
RoW
VM-1500A-LAI, VM-1500, VM-1500A
Viriom
HIV-1-infection
03/20
05/20
NCT05148754: An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Completed
1
15
RoW
Elsulfavirine, VM-1500
Viriom
Covid19, HIV-1-infection
08/21
08/21
NCT05165550: Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects

Completed
1
24
US
Elsulfavirine, VM-1500
Viriom
HIV-1-infection
07/22
07/22

Download Options